Study on Industry-university-research Cooperation Model and Network Evolution of Pharmaceutical Manufac- turing Industry
返回论文页
|更新时间:2022-06-21
|
Study on Industry-university-research Cooperation Model and Network Evolution of Pharmaceutical Manufac- turing Industry
China PharmacyVol. 32, Issue 13, (2021)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2021,
扫 描 看 全 文
YAN Juanjuan, HU Anxia, PEI Zhongyang. Study on Industry-university-research Cooperation Model and Network Evolution of Pharmaceutical Manufac- turing Industry. [J]. China Pharmacy 32(13).(2021)
DOI:
YAN Juanjuan, HU Anxia, PEI Zhongyang. Study on Industry-university-research Cooperation Model and Network Evolution of Pharmaceutical Manufac- turing Industry. [J]. China Pharmacy 32(13).(2021)DOI:
Study on Industry-university-research Cooperation Model and Network Evolution of Pharmaceutical Manufac- turing Industry
OBJECTIVE:To study industry-university-resear ch cooperation model and network evolution characteristics of pharmaceutical manufacturing industry in China ,and to provide decision-making basis for pharmaceutical innovation cooperation. METHODS:Using social network analysis method ,based on industry-university-research cooperation patent data of pharmaceutical manufacturing industry during 1998-2019,the patent cooperation network of pharmaceutical manufacturing industry in China was established,and the structural parameters were calculated and evolution regularity of the network were analyzed. RESULTS : Industry-university-research cooperation patents in the pharmaceutical manufacturing industry were affected by drug innovation policies. The scale of innovation network in pharmaceutical manufacturing industry was expanding day by day ;the density of innovation network was decreasing gradually ;it was not characterized with typical small world features. CONCLUSIONS :It is suggested to strengthen the scientific and technological support to the core innovation subjects (universities and research institutions),and improve the cooperation with enterprises ;optimize the drug innovation policy environment ,encourage more innovation subjects to participate in the drug R&D process ;construct a platform for industry-university-research collaborative innovation,build drug R&D mechanism which can promote industry-university-research cooperation ,reduce the number of intermediaries in cooperation ,optimize the allocation of drug R&D resources and promote cooperative innovation of enterprises.